"It is an important prerequisite for global sustainable development and high-quality development that all countries jointly build a human health community and provide the most valuable and healthy human resources for development." At the sub forum of the fifth Hongqiao International Economic Forum on "Promoting high-quality industrial development and jointly building a community of human health", Zhou Liang, the moderator of the forum, secretary of the Party Committee of the Economic Reference News Agency of Xinhua News Agency and chief editor, pointed out the significance of jointly building a community of human health. As he said, in the process of high-quality development of the global health industry, openness and win-win cooperation among countries are the key. "Biomedical innovation has become an important symbol of China's entry into an innovative country." Deputy Director of the Economic Committee of the CPPCC National Committee Bi Jingquan, Executive Vice President of China International Economic Exchange Center, pointed out that: "Biomedicine is one of the fields with the highest scientific and technological content, the most intensive innovation and the most active investment in the new round of scientific and technological change in the world. In the past eight years, China has invested 1.5 trillion yuan in the research and development of biomedicine and medical devices. In the past ten years, China has approved about 15% of new drugs for listing in the world, and more than 5500 new drug clinical trials have been carried out in China." "In the past decade, China has been vigorously promoting innovation with a miraculous' China speed '." He Lei, president of Stryker China, said in his speech at the forum: "Foresight technology promotes medical innovation, which is one of the logic of Stryker's development. We will also continue to apply cutting-edge technologies to the Chinese medical market." Avram Heshko, winner of the 2004 Nobel Prize in Chemistry, an academician of the Israeli Academy of Sciences and a foreign academician of the Chinese Academy of Sciences, believes that basic research is the core of all important innovations in the pharmaceutical industry. "For example, the discovery of penicillin is an example, which has prompted the discovery of many other antibiotics, thus fundamentally changing the treatment of infectious diseases. Medical history shows that almost every major improvement of human health is based on some important discoveries of basic research." He pointed out: "If we want to achieve highly original innovation in the industry, society should support high-quality basic research." "Since the outbreak, China has built two barriers in response to the COVID-19. Vaccine is the first barrier, and the second is traditional Chinese medicine." Zhang Boli, academician of the CAE Member, made a speech at the forum based on the successful anti epidemic experience of combining Chinese and western medicine and combining Chinese and western medicine, pointing out that the modernization of Chinese medicine must be integrated with modern science and technology, adhere to the idea of "Chinese medicine thinking+original+modern science and technology+transformation", and promote industrial development through innovation. Zhang Boli then said his understanding of the modernization of traditional Chinese medicine: "It is necessary to let modern science and technology support 'seeing, hearing and inquiring', and use modern research to interpret the mechanism of the role of traditional Chinese medicine, so that modern people and the modern scientific and technological community can more easily accept traditional Chinese medicine and make traditional Chinese medicine more rationally used." For the modernization of traditional Chinese medicine, Lin Guoqiang, an academician of the CAS Member and president of the Innovation Institute of Traditional Chinese Medicine of Shanghai University of Traditional Chinese Medicine, pointed out that with the standardization of the quality control system and key technology system of traditional Chinese medicine, the internationalization of traditional Chinese medicine has been accelerated, but the sense of existence of traditional Chinese medicine in the global market is not strong. "In terms of the international market, about 80% of the world's pharmaceutical and medicated food raw materials come from China